Switch theme
Sign up to access all valuation multiples
AmoreG is a manufacturer of personal care products and cosmetics. The company manufactures, markets and trades of cosmetics, personal care goods, and other related products. It also provides skin evaluation services, which measures, dryness, pollutants, and sensitivity of the skin. The company’s products portfolio includes Creams, Toner and Fluids, Ampoule, Cleansing, Eye Care, Serum, Sun Care, Body Care, and Special Care.
1945
n/a
LTM Revenue $2.9B
LTM EBITDA $378M
$421M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
AmoreG has a last 12-month revenue of $2.9B and a last 12-month EBITDA of $378M.
In the most recent fiscal year, AmoreG achieved revenue of $2.9B and an EBITDA of $673M.
AmoreG expects next 12-month revenue of XXX and NTM EBITDA of XXX
See AmoreG valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $2.7B | $2.9B | XXX | XXX | XXX |
| Gross Profit | $2.1B | $1.9B | XXX | XXX | XXX |
| Gross Margin | 78% | 67% | XXX | XXX | XXX |
| EBITDA | $429M | $673M | XXX | XXX | XXX |
| EBITDA Margin | 16% | 23% | XXX | XXX | XXX |
| Net Profit | $42.4M | $81.3M | XXX | XXX | XXX |
| Net Margin | 2% | 3% | XXX | XXX | XXX |
| Net Debt | n/a | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, AmoreG's stock price is KRW 18596 (or $13).
AmoreG has current market cap of KRW 1.67T (or $1.1B), and EV of KRW 618B (or $421M).
See AmoreG trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $421M | $1.1B | XXX | XXX | XXX | XXX | $1.72 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, AmoreG has market cap of $1.1B and EV of $421M.
AmoreG's trades at 0.1x LTM EV/Revenue multiple, and 1.1x LTM EBITDA.
Analysts estimate AmoreG's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for AmoreG and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $421M | XXX | XXX | XXX |
| EV/Revenue | 0.1x | XXX | XXX | XXX |
| EV/EBITDA | 0.6x | XXX | XXX | XXX |
| P/E | 6.6x | XXX | XXX | XXX |
| P/E/Growth | 0.6x | XXX | XXX | XXX |
| EV/FCF | 2.3x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpAmoreG's NTM/LTM revenue growth is 5%
AmoreG's revenue per employee for the last fiscal year averaged n/a, while opex per employee averaged n/a for the same period.
Over next 12 months, AmoreG's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate AmoreG's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for AmoreG and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 6% | XXX | XXX | XXX | XXX |
| EBITDA Margin | 23% | XXX | XXX | XXX | XXX |
| EBITDA Growth | 57% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | 29% | XXX | XXX | XXX | XXX |
| Revenue per Employee | n/a | XXX | XXX | XXX | XXX |
| Opex per Employee | n/a | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | 36% | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | 5% | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | 2% | XXX | XXX | XXX | XXX |
| Opex to Revenue | 66% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Acme United | XXX | XXX | XXX | XXX | XXX | XXX |
| EZZ Life Science | XXX | XXX | XXX | XXX | XXX | XXX |
| Live Verdure | XXX | XXX | XXX | XXX | XXX | XXX |
| Lavipharm | XXX | XXX | XXX | XXX | XXX | XXX |
| Sarantis Group | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
AmoreG acquired XXX companies to date.
Last acquisition by AmoreG was XXXXXXXX, XXXXX XXXXX XXXXXX . AmoreG acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was AmoreG founded? | AmoreG was founded in 1945. |
| Where is AmoreG headquartered? | AmoreG is headquartered in South Korea. |
| Who is the CEO of AmoreG? | AmoreG's CEO is Mr. Kyung-Bae Seo. |
| Is AmoreG publicy listed? | Yes, AmoreG is a public company listed on KRX. |
| What is the stock symbol of AmoreG? | AmoreG trades under 002790 ticker. |
| When did AmoreG go public? | AmoreG went public in 1973. |
| Who are competitors of AmoreG? | Similar companies to AmoreG include e.g. Acme United, EZZ Life Science, Live Verdure, Lavipharm. |
| What is the current market cap of AmoreG? | AmoreG's current market cap is $1.1B |
| What is the current revenue of AmoreG? | AmoreG's last 12-month revenue is $2.9B. |
| What is the current EBITDA of AmoreG? | AmoreG's last 12-month EBITDA is $378M. |
| What is the current EV/Revenue multiple of AmoreG? | Current revenue multiple of AmoreG is 0.1x. |
| What is the current EV/EBITDA multiple of AmoreG? | Current EBITDA multiple of AmoreG is 1.1x. |
| What is the current revenue growth of AmoreG? | AmoreG revenue growth between 2023 and 2024 was 6%. |
| Is AmoreG profitable? | Yes, AmoreG is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
